Epidemiological analysis of congenital heart disease in Beijing from 2017 to 2021

doi:10.3877/cma.j.issn.1673-5250.2023.01.009

Objective

To explore the epidemiological characteristics of fetal and neonatal congenital heart disease (CHD) in Beijing by analyzing the surveillance data of CHD in recent years.

Methods

From January 2017 to December 2021, a total of 985 603 perinatal infants were monitored in the Beijing Birth Defects Surveillance System, among which 11 356 fetuses/newborns were diagnosed with CHD, including intrauterine stillbirth, therapeutic induction of labor fetus and live birth, stillbirth and neonatal death within 7 d after birth. These 11 356 CHD fetuses/newborns were selected in study. From 2017 to 2021, the number of diagnosed CHD fetuses/newborns and monitored perinatal infants were 2 113 cases vs 243 438 cases, 2 276 cases vs 214 333 cases, 2 426 cases vs 218 922 cases, 2 192 cases vs 161 605 cases, and 2 349 cases vs 147 305 cases, respectively. By means of descriptive epidemiological analysis method, the overall incidence of CHD and the incidence of different types of CHD were analyzed in fetal/newborn population with gestational age of 13 weeks to 7 d after birth (observation period) and gestational age of 28 weeks to 7 d after birth (perinatal period) in Beijing Birth Defects Surveillance System. The procedures followed in this study were in line with World Medical Association Declaration of Helsinki revised in 2013.

Results

①From 2017 to 2021, the overall incidence of CHD in fetal/neonatal population was 1.15% (11 356/985 603) during observation period of Beijing Birth Defects Surveillance System. And the incidence of CHD during observation period from 2017 to 2021 was 0.87% (2 113/243 438), 1.06% (2 276/214 333), 1.11% (2 426/218 922), 1.36% (2 192/161 605) and 1.59% (2 349/147 305) respectively, which showed an increasing trend. The chromosomal abnormality rate of 11 356 CHD fetuses/newborns was 3.90% (444 cases), and the top three chromosomal abnormality were trisomy 18 (127 cases, 28.60%), trisomy 21 (104 cases, 23.42%) and 22q11.2 deletion syndrome (19 cases, 4.28%). The incidence of extracardiac malformations of 11 356 CHD fetuses/newborns was 11.91% (1 351/11 356), and the proportion of malformations other than cardiovascular and circulatory system in descending order was musculoskeletal system (326 cases, 24.13%), urinary system (248 cases, 18.36%) and nervous system (202 cases, 14.95%). The incidence of severe congenital heart disease (CCHD) was 0.20% (1 938/985 603). ②Among 11 356 CHD fetuses/newborns, 8 882 cases were diagnosed in perinatal period, and the overall incidence of perinatal CHD was 0.90% (8 882/985 603). The incidence of perinatal CHD from 2017 to 2021 was 0.62% (1 520/243 438), 0.82% (1 868/214 333), 0.86% (1 892/218 922), 1.12% (1 808/161 605), 1.30% (1 910/147 305) respectively, which also showed an increasing trend. The incidence of isolated atrial septal defect of perinatal CHD fetuses/newborns in 2021 was 0.36% (527/147 305), which was 4.33 times higher than that in 2017 (0.08%, 201/243 438), and its absolute increase in incidence accounted for 40.18% of the total absolute increase in the incidence of perinatal CHD. The top five CHD types in perinatal period were atrial septal defect (2 704 cases), ventricular septal defect (2 592 cases), patent ductus arteriosus (2 233 cases), patent foramen ovale (1 767 cases), and permanent left superior vena cava (478 cases). The incidence of perinatal CCHD was 0.04% (433/985 603).

Conclusions

From 2017 to 2021, the incidences of CHD in observation period and perinatal period in Beijing both show an increasing trend. The increase in incidence of CHD is mainly concentrated in simple atrial septal defect. The incidence of perinatal of CCHD is at a low level.

Key words: Congenital heart diseases, Critical congenital heart defects, Incidence, Epidemiologic studies, Heart septal defects, atrial, Heart septal defects, ventricular, Ductus arteriosus, patent, Foramen ovale, patent, Peripartum period, Fetus, Infant, newborn

表1 2017—2021年，观察期与围产期内北京市出生缺陷监测系统对985 603例围产儿不同分型CHD胎儿/新生儿监测结果

不同分型CHD	观察期		围产期
不同分型CHD	例数	发生率(×10^－4)	例数	发生率(×10^－4)
房间隔缺损	2 742	27.82	2 704	27.43
室间隔缺损	3 490	35.41	2 592	26.30
动脉导管未闭	2 233	22.66	2 233	22.66
卵圆孔未闭	1 767	17.93	1 767	17.93
永存左上腔静脉	677	6.87	478	4.85
右位主动脉弓	336	3.41	233	2.36
肺动脉/肺动脉瓣狭窄	425	4.31	179	1.82
法洛四联症	547	5.55	125	1.27
主动脉狭窄	236	2.39	97	0.98
完全性大动脉转位	270	2.74	82	0.83
完全性肺静脉异位引流	105	1.07	44	0.45
肺动脉闭锁	212	2.15	27	0.27
主动脉弓离断	98	0.99	22	0.22
右心室双出口	247	2.51	17	0.17
三尖瓣下移	44	0.45	17	0.17
永存动脉干	119	1.21	11	0.11
单心室	217	2.20	8	0.08
左心发育不良	171	1.73	7	0.07
三尖瓣闭锁	39	0.40	5	0.05
房室间隔缺损	270	2.74	35	0.36
心律失常	43	0.44	22	0.22
横纹肌瘤	61	0.62	37	0.38
心肌疾病	26	0.26	14	0.14
其他分型CHD	410	4.16	240	2.44

表1 2017—2021年，观察期与围产期内北京市出生缺陷监测系统对985 603例围产儿不同分型CHD胎儿/新生儿监测结果

不同分型CHD	观察期		围产期
不同分型CHD	例数	发生率(×10^－4)	例数	发生率(×10^－4)
房间隔缺损	2 742	27.82	2 704	27.43
室间隔缺损	3 490	35.41	2 592	26.30
动脉导管未闭	2 233	22.66	2 233	22.66
卵圆孔未闭	1 767	17.93	1 767	17.93
永存左上腔静脉	677	6.87	478	4.85
右位主动脉弓	336	3.41	233	2.36
肺动脉/肺动脉瓣狭窄	425	4.31	179	1.82
法洛四联症	547	5.55	125	1.27
主动脉狭窄	236	2.39	97	0.98
完全性大动脉转位	270	2.74	82	0.83
完全性肺静脉异位引流	105	1.07	44	0.45
肺动脉闭锁	212	2.15	27	0.27
主动脉弓离断	98	0.99	22	0.22
右心室双出口	247	2.51	17	0.17
三尖瓣下移	44	0.45	17	0.17
永存动脉干	119	1.21	11	0.11
单心室	217	2.20	8	0.08
左心发育不良	171	1.73	7	0.07
三尖瓣闭锁	39	0.40	5	0.05
房室间隔缺损	270	2.74	35	0.36
心律失常	43	0.44	22	0.22
横纹肌瘤	61	0.62	37	0.38
心肌疾病	26	0.26	14	0.14
其他分型CHD	410	4.16	240	2.44

图1 2017—2021年北京市围产期单纯动脉导管未闭、卵圆孔未闭、房间隔缺损、室间隔缺损及轻型CHD、CHD总体发生率变化趋势图注：轻型CHD指单纯房间隔缺损/卵圆孔未闭/室间隔缺损/动脉导管未闭。CHD为先天性心脏病

[1]	Centers for Disease Control and Prevention. Critical congenital heart defects in the United State[EB/OL]. (2014-07-09)[2022-04-20]. URL
[2]	张雯，徐宏燕，张彦春，等. 北京市胎儿及婴儿先天性脑积水发生情况及婴儿期转归[J/OL]. 中华妇幼临床医学杂志(电子版), 2021, 17(6): 657-662. DOI: 10.3877/cma.j.issn.1673-5250.2021.06.006.
[3]	中华人民共和国卫生健康委员会. 国际疾病分类第十一次修订本(ICD-11)中文版[M]. 北京：人民卫生出版社，2018: 455-486.
[4]	中国出生缺陷监测中心，全国妇幼卫生监测办公室. 中国出生缺陷监测系统疑难和微小畸形报告指南(试用版2012)[EB/OL]. (2011-11-01)[2022-04-20]. URL
[5]	Zhang Y, Riehle-Colarusso T, Correa A, et al. Observed prevalence of congenital heart defects from a surveillance study in China[J]. J Ultrasound Med, 2011, 30(7): 989-995. DOI: 10.7863/jum.2011.30.7.989.
[6]	Bernier PL, Stefanescu A, Samoukovic G, et al. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts[J]. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2010, 13(1): 26-34. DOI: 10.1053/j.pcsu.2010.02.005.
[7]	van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and Meta-analysis[J]. J Am Coll Cardiol, 2011, 58(21): 2241-2247. DOI: 10.1016/j.jacc.2011.08.025.
[8]	Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and Meta-analysis of 260 studies[J]. Int J Epidemiol, 2019, 48(2): 455-463. DOI: 10.1093/ije/dyz009.
[9]	Yu Z, Li D, Sun L, et al. Long-term trends in the incidence of congenital anomalies in Central China from 1997 to 2019[J]. Public Health, 2022, 203: 47-52. DOI: 10.1016/j.puhe.2021.12.007.
[10]	中华人民共和国卫生健康委员会妇幼健康司. 2020全国妇幼健康信息分析报告[R]. 北京：国卫生健康委员会妇幼健康司，2020: 77-78.
[11]	Zhao L, Chen L, Yang T, et al. Birth prevalence of congenital heart disease in China, 1980-2019: a systematic review and Meta-analysis of 617 studies[J]. Eur J Epidemiol, 2020, 35(7): 631-642. DOI: 10.1007/s10654-020-00653-0.
[12]	Bakker MK, Bergman JEH, Krikov S, et al. Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study[J]. BMJ Open, 2019, 9(7): e028139. DOI: 10.1136/bmjopen-2018-028139.
[13]	Taylor K, Thomas R, Mumme M, et al. Ascertaining and classifying cases of congenital anomalies in the ALSPAC birth cohort[J]. Open Res, 2021, 5: 231. DOI: 10.12688/wellcomeopenres.16339.2. .
[14]	张雯，刘凯波，徐宏燕，等. 北京地区复杂先天性心脏病发生及婴儿期转归情况[J]. 中国优生与遗传杂志，2016, 24(8): 88-90 . DOI: 10.13404/j.cnki.cjbhh.2016.08.040.
[15]	Zhao QM, Liu F, Wu L，et al. Prevalence of congenital heart disease at live birth in China[J]. J Pediatr, 2019, 204: 53-58. DOI: 10.1016/j.jpeds.2018.08.040.
[16]	Zhang W, Xu HY, Liu KB. Delayed diagnosis of critical congenital heart effects predicting risk factors and survival rate in newborns in Beijing: a retrospective study[J]. J Int Med Res, 2021, 49(7): 3000605211028028. DOI: 10.1177/03000605211028028.
[17]	Hoang TT, Goldmuntz E, Roberts AE, et al. The Congenital Heart Disease Genetic Network Study: cohort description[J]. PLoS One, 2018, 13(1): e0191319. DOI: 10.1371/journal.pone.0191319.
[18]	Yamagishi H, Srivastava D. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome[J]. Trends Mol Med, 2003, 9(9): 383-389. DOI: 10.1016/s1471-4914(03)00141-2.
[19]	Panamonta V, Wichajarn K, Chaikitpinyo A, et al. Birth prevalence of chromosome 22q11.2 deletion syndrome: a systematic review of population-based studies[J]. J Med Assoc Thai, 2016, 99(Suppl 5): S187-S193.
[20]	Aoki Y, Niihori T, Inouse S, et al. Recent advances in RASopathies[J]. J Hum Genet, 2016, 61(1): 33-39. DOI: 10.1038/jhg.2015.114.
[21]	Croonen EA, Nillesen WM, Stuurman KE, et al. Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings[J]. Eur J Hum Genet, 2013, 21(9): 936-942. DOI: 10.1038/ejhg.2012.285.
[22]	Roberts AE, Allanson JE, Tartaglia M, et al. Noonan syndrome[J]. Lancet, 2013, 381(9863): 333-342. DOI: 10.1016/S0140-6736(12)61023-X.
[23]	Li X, Yao R, Tan X, et al. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients[J]. Clin Genet, 2019, 96(4): 290-299. DOI: 10.1111/cge.13588.

[1]	Xining Wu, Yunshu Ouyang, Yixiu Zhang, Hua Meng, Zhonghui Xu, Peipei Zhang, Ke Lyu. Application of fetal echocardiography in prenatal management of fetuses with positive maternal anti-SSA/Ro-SSB/La antibodies[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1056-1060.
[2]	Shuihua Yang, Guidan He, Guican Qin, Mengfeng Liang, Yanhe Luo, Xueqin Li, Juansong Tang. Echocardioimagedata characteristics of fetal isolated total anomalous pulmonary venous connection and application of high definition flow imaging and spatio-temporal image correlation[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1061-1067.
[3]	Jingjing Zhang, Bowen Zhao, Mei Pan, Xiaohui Peng, Yankai Mao, Chenke Pan, Lingyan Zhu, Linlin Zhu, Qiuye Lan. Evaluation of fetal pulmonary development using McGoon index measured by fetal echocardiography[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 860-865.
[4]	Peng Xu, Jun Li, Weilun Gao, Zheng Wang, Shen Pang, Chunni Li, Ting Zhu. Application of fast rotary scanning method in fetal echocardiography[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 761-766.
[5]	Gang Luo, Silin Pan, Taotao Chen, Qian Xu, Zhixian Ji, Sibao Wang, Lingyu Sun. Application of echocardiography in fetal cardiac intervention of pulmonary atresia with intact ventricular septum[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(06): 605-609.
[6]	Jia Huang, Hua Shi, Yuguo Zhang, Jiaqi Hu, Qian Chen. Ultrasonographic features of normal and abnormal fetal left brachiocephalic vein and their clinical significance[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(06): 610-617.
[7]	Ze Yuan, Li Zhuang. Value of ultrasound detection of fetal umbilical artery and middle cerebral artery blood flow in diagnosis of fetal intrauterine distress[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(06): 618-621.
[8]	Bo Li, Dexuan Kong, Fanghua Peng, Wenying Wu. Value of ultrasound in diagnosis of fetal anomalous pulmonary venous connection[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(04): 437-441.
[9]	Yinhua Hu, Long Xue. Incidence and risk factors of symptomatic knee arthritis in middle-aged and elderly people in China[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(04): 470-478.
[10]	Chao Xue, Ye Zhang, Ying Zhao, Jiancheng Han, Xiaoyan Gu, Lin Sun, Xiaowei Liu, Wei Song, Yihua He. Ultrasonographic characteristics and prognosis of fetal congenital absent pulmonary valve syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 410-418.
[11]	Yuting Wei, Hong Luo. Current research status of ultrasound elastography on evaluation of fetal growth restriction[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 256-260.
[12]	Wen Zhang, Yanchun Zhang, Kaibo Liu, Hongyan Xu. Prenatal MRI diagnosis and perinatal outcome of fetal congenital hydrocephalus in Beijing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 345-349.
[13]	Yonghuan Mao, Hanwen Tong, Ji Miao, Xingzhou Wang, Xiaofei Shen, Chunzhao Yu. Analysis of risk factors and prediction model of parastomal hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 682-687.
[14]	Yunlin Li, Donghua Lou. Analysis on the influencing factors of the incidence and remission of non-alcoholic fatty liver disease in Binhai County[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 354-358.
[15]	Yanli Zou, Wenjie Luan, Shujuan Wang, Yaqin Liu, Guizhi Chu, Songyang Li, Haoling Wang, Jinting Zhang, Xin Jiang, Zedong Luan. Ultrasonographic features of fetal right aortic arch in the first trimester[J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(04): 227-232.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export